AIRLINK 74.29 Increased By ▲ 0.29 (0.39%)
BOP 4.95 Decreased By ▼ -0.07 (-1.39%)
CNERGY 4.37 Decreased By ▼ -0.05 (-1.13%)
DFML 38.80 Decreased By ▼ -0.40 (-1.02%)
DGKC 84.82 Decreased By ▼ -1.27 (-1.48%)
FCCL 21.21 Decreased By ▼ -0.44 (-2.03%)
FFBL 34.12 Increased By ▲ 0.11 (0.32%)
FFL 9.70 Decreased By ▼ -0.22 (-2.22%)
GGL 10.42 Decreased By ▼ -0.14 (-1.33%)
HBL 113.00 Decreased By ▼ -0.89 (-0.78%)
HUBC 136.20 Increased By ▲ 0.36 (0.27%)
HUMNL 11.90 No Change ▼ 0.00 (0%)
KEL 4.71 Decreased By ▼ -0.13 (-2.69%)
KOSM 4.44 Decreased By ▼ -0.09 (-1.99%)
MLCF 37.65 Decreased By ▼ -0.62 (-1.62%)
OGDC 136.20 Increased By ▲ 1.35 (1%)
PAEL 25.10 Decreased By ▼ -1.25 (-4.74%)
PIAA 19.24 Decreased By ▼ -1.56 (-7.5%)
PIBTL 6.71 Increased By ▲ 0.03 (0.45%)
PPL 122.10 Decreased By ▼ -0.90 (-0.73%)
PRL 26.65 Decreased By ▼ -0.04 (-0.15%)
PTC 13.93 Decreased By ▼ -0.40 (-2.79%)
SEARL 57.22 Decreased By ▼ -1.90 (-3.21%)
SNGP 67.60 Decreased By ▼ -1.90 (-2.73%)
SSGC 10.25 Decreased By ▼ -0.08 (-0.77%)
TELE 8.40 Decreased By ▼ -0.10 (-1.18%)
TPLP 11.13 Decreased By ▼ -0.10 (-0.89%)
TRG 62.81 Decreased By ▼ -2.04 (-3.15%)
UNITY 26.50 Increased By ▲ 0.25 (0.95%)
WTL 1.35 Increased By ▲ 0.01 (0.75%)
BR100 7,800 Decreased By -50.5 (-0.64%)
BR30 25,138 Decreased By -198.6 (-0.78%)
KSE100 74,957 Decreased By -250.1 (-0.33%)
KSE30 24,083 Decreased By -59.5 (-0.25%)

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed.